Targeting Oncogenic BRAF in Human Cancer
Current topics in microbiology and immunology2010Vol. 355, pp. 83–98
Citations Over TimeTop 10% of 2010 papers
Related Papers
- → Vemurafenib(2018)71 cited
- → Vemurafenib(2014)32 cited
- → The Response of Cancers to BRAF Inhibition Underscores the Importance of Cancer Systems Biology(2012)24 cited
- → Abstract LB-428: RAS-independent dimerization of BRAF(V600E) splicing variants promotes resistance to RAF inhibitors(2012)
- → Faculty Opinions recommendation of RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).(2011)